How individual and neighborhood factors affect brain responses to smoking cues across different racial groups
Official title: Impact of individual- and neighborhood-level risk factors on brain responses to smoking cues among and across racial groups
Funded at University of Wisconsin Milwaukee · NIH-10664822 · Data updated 2026-11-12
This study looks at how personal and community factors affect how our brains respond to smoking triggers, especially focusing on why some racial groups, like African Americans, face more smoking-related health issues even when they smoke the same amount as others, with the goal of finding better ways to help everyone quit smoking.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin Milwaukee NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project start | July 15, 2022 |
| Project end | June 30, 2025 |
| Funding year | 2023 |
| Award (this year) | $87,445 |
| NIH project number | 5R03DA055140-02 |
| Project ID | NIH-10664822 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adult smokers, particularly those from African American and other racial minority backgrounds.
✕Less likely to help
Patients who do not smoke or are not part of the targeted racial groups may not receive benefits from this research.
What this research studies
This research investigates how both personal and community-level factors influence brain reactions to smoking cues, particularly focusing on racial disparities. It aims to understand why certain racial groups, like African Americans, experience higher rates of smoking-related diseases despite similar smoking rates compared to other groups. By examining neurobiological responses, the study seeks to identify potential reasons for differences in smoking cessation success. The findings could lead to more tailored and effective smoking cessation interventions for diverse populations.
Why it matters
Potential benefit: If successful, this research could lead to improved smoking cessation strategies that are more effective for different racial and ethnic groups.
How similar studies have gone: While there has been some research on smoking cessation, this study's focus on racial differences in neurobiological responses to smoking cues is relatively novel.
Where this research is happening
-
University of Wisconsin Milwaukee
Milwaukee, United States Active
Researchers
- Principal investigator: Do, D. Phuong — University of Wisconsin Milwaukee
- Study coordinator: Do, D. Phuong
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
ALS risk factors in a long-term ALS study
A long-term ALS study is looking at which factors may influence disease risk and progression in people living with ALS.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
P-CARRS-BRAIN: Predicting Alzheimer’s risk in South Asians in India using genetic, behavior, and vascular data
Aims to predict Alzheimer’s disease risk in middle-aged South Asians by combining genetic, lifestyle, and vascular information to catch early changes before dementia develops.
-
P-CARRS-BRAIN: Predicting Alzheimer’s risk in South Asians in India using genetics, behavior, and vascular data
Aimed at people 21 and older, this project looks at how biology, behavior, and blood vessel health together may signal the early risk of Alzheimer’s disease and related dementias in South Asians.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.